BDBM492872 N-((5-chloro-1H- indazol-3-yl)methyl)-5- (2- (trifluoromethyl)benzyl) nicotinamide::US10981893, Example 1

SMILES O=C(NCc1n[nH]c2ccc(Cl)cc12)c1cncc(Cc2ccccc2C(F)(F)F)c1

InChI Key InChIKey=CNBJJXVVRQKAFE-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 492872   

TargetPlasma kallikrein(Human)
Attune Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 492872BDBM492872(US10981893, Example 1 | N-((5-chloro-1H- indazol-3...)
Affinity DataIC50: 5.50E+3nMAssay Description:The ability of the compounds disclosed herein to inhibit human plasma kallikrein activity was quantified according to the procedures below.A 10 mM so...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/26/2021
Entry Details
US Patent